Emily Mullin is a science journalist with nearly 15 years of experience, currently serving as a staff writer at WIRED, where she covers biotechnology, gene editing, neurotechnology, synthetic biology, reproductive technology, and the obesity drug revolution. Her reporting focuses on how humans are reprogramming biology to reshape bodies and environments, and the profound consequences of these innovations. Mullin’s work has been recognized by the D.C. Science Writers Association and the National Institute for Healthcare Management, and she was awarded the prestigious MIT Knight Science Journalism Project Fellowship in 2021 to research the science, history, and ethics of cross-species organ transplantation.

Before joining WIRED, Mullin held editorial positions at the Pittsburgh Post-Gazette, Medium’s OneZero, and MIT Technology Review, where she specialized in biomedicine. Her stories have also appeared in The New York Times, The Washington Post, Wall Street Journal, Scientific American, National Geographic, and Smithsonian Magazine. With a bachelor’s degree in journalism from Ohio University and a master’s in science writing from Johns Hopkins University, she has combined rigorous reporting with accessible storytelling. Mullin has also taught courses in the Johns Hopkins science writing program, sharing her expertise with the next generation of science communicators.

Based in Pittsburgh, Pennsylvania, Mullin balances her professional life with a passion for the outdoors, including hiking, biking, and climbing, as well as volunteering in local conservation areas. Her career reflects a deep commitment to exploring the intersection of science, technology, and society, while making complex biomedical advances understandable to broad audiences. Through her reporting, she continues to illuminate how biotechnology is reshaping the human experience and the ethical questions that arise from these transformations.